188 related articles for article (PubMed ID: 28348375)
1. A redox-mediated Kemp eliminase.
Li A; Wang B; Ilie A; Dubey KD; Bange G; Korendovych IV; Shaik S; Reetz MT
Nat Commun; 2017 Mar; 8():14876. PubMed ID: 28348375
[TBL] [Abstract][Full Text] [Related]
2. A rapid screening for cytochrome P450 catalysis on new chemical entities: cytochrome P450 BM3 and 1,2,5-oxadiazole derivatives.
Tsotsou GE; Di Nardo G; Sadeghi SJ; Fruttero R; Lazzarato L; Bertinaria M; Gilardi G
J Biomol Screen; 2013 Feb; 18(2):211-8. PubMed ID: 22983164
[TBL] [Abstract][Full Text] [Related]
3. Engineering a self-sufficient Mycobacterium tuberculosis CYP130 by gene fusion with the reductase-domain of CYP102A1 from Bacillus megaterium.
Ortega Ugalde S; Luirink RA; Geerke DP; Vermeulen NPE; Bitter W; Commandeur JNM
J Inorg Biochem; 2018 Mar; 180():47-53. PubMed ID: 29232638
[TBL] [Abstract][Full Text] [Related]
4. A novel semi-biosynthetic route for artemisinin production using engineered substrate-promiscuous P450(BM3).
Dietrich JA; Yoshikuni Y; Fisher KJ; Woolard FX; Ockey D; McPhee DJ; Renninger NS; Chang MC; Baker D; Keasling JD
ACS Chem Biol; 2009 Apr; 4(4):261-7. PubMed ID: 19271725
[TBL] [Abstract][Full Text] [Related]
5. Expression, purification, and characterization of Bacillus subtilis cytochromes P450 CYP102A2 and CYP102A3: flavocytochrome homologues of P450 BM3 from Bacillus megaterium.
Gustafsson MC; Roitel O; Marshall KR; Noble MA; Chapman SK; Pessegueiro A; Fulco AJ; Cheesman MR; von Wachenfeldt C; Munro AW
Biochemistry; 2004 May; 43(18):5474-87. PubMed ID: 15122913
[TBL] [Abstract][Full Text] [Related]
6. Enantioselective epoxidation of linolenic acid catalysed by cytochrome P450(BM3) from Bacillus megaterium.
Celik A; Sperandio D; Speight RE; Turner NJ
Org Biomol Chem; 2005 Aug; 3(15):2688-90. PubMed ID: 16032346
[TBL] [Abstract][Full Text] [Related]
7. Structural basis of steroid binding and oxidation by the cytochrome P450 CYP109E1 from Bacillus megaterium.
Jóźwik IK; Kiss FM; Gricman Ł; Abdulmughni A; Brill E; Zapp J; Pleiss J; Bernhardt R; Thunnissen AW
FEBS J; 2016 Nov; 283(22):4128-4148. PubMed ID: 27686671
[TBL] [Abstract][Full Text] [Related]
8. Insights into regioselective metabolism of mefenamic acid by cytochrome P450 BM3 mutants through crystallography, docking, molecular dynamics, and free energy calculations.
Capoferri L; Leth R; ter Haar E; Mohanty AK; Grootenhuis PD; Vottero E; Commandeur JN; Vermeulen NP; Jørgensen FS; Olsen L; Geerke DP
Proteins; 2016 Mar; 84(3):383-96. PubMed ID: 26757175
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic Study of the Stereoselective Hydroxylation of [2-
Yang CL; Lin CH; Luo WI; Lee TL; Ramu R; Ng KY; Tsai YF; Wei GT; Yu SS
Chemistry; 2017 Feb; 23(11):2571-2582. PubMed ID: 27798822
[TBL] [Abstract][Full Text] [Related]
10. The bacterial P450 BM3: a prototype for a biocatalyst with human P450 activities.
Yun CH; Kim KH; Kim DH; Jung HC; Pan JG
Trends Biotechnol; 2007 Jul; 25(7):289-98. PubMed ID: 17532492
[TBL] [Abstract][Full Text] [Related]
11. Biochemical and structural characterization of CYP109A2, a vitamin D
Abdulmughni A; Jóźwik IK; Brill E; Hannemann F; Thunnissen AWH; Bernhardt R
FEBS J; 2017 Nov; 284(22):3881-3894. PubMed ID: 28940959
[TBL] [Abstract][Full Text] [Related]
12. Application of engineered cytochrome P450 mutants as biocatalysts for the synthesis of benzylic and aromatic metabolites of fenamic acid NSAIDs.
Venkataraman H; Verkade-Vreeker MC; Capoferri L; Geerke DP; Vermeulen NP; Commandeur JN
Bioorg Med Chem; 2014 Oct; 22(20):5613-20. PubMed ID: 24999003
[TBL] [Abstract][Full Text] [Related]
13. Filling a hole in cytochrome P450 BM3 improves substrate binding and catalytic efficiency.
Huang WC; Westlake AC; Maréchal JD; Joyce MG; Moody PC; Roberts GC
J Mol Biol; 2007 Oct; 373(3):633-51. PubMed ID: 17868686
[TBL] [Abstract][Full Text] [Related]
14. Improved cyclopropanation activity of histidine-ligated cytochrome P450 enables the enantioselective formal synthesis of levomilnacipran.
Wang ZJ; Renata H; Peck NE; Farwell CC; Coelho PS; Arnold FH
Angew Chem Int Ed Engl; 2014 Jun; 53(26):6810-3. PubMed ID: 24802161
[TBL] [Abstract][Full Text] [Related]
15. Molecular Dynamics and QM/MM Calculations Predict the Substrate-Induced Gating of Cytochrome P450 BM3 and the Regio- and Stereoselectivity of Fatty Acid Hydroxylation.
Dubey KD; Wang B; Shaik S
J Am Chem Soc; 2016 Jan; 138(3):837-45. PubMed ID: 26716578
[TBL] [Abstract][Full Text] [Related]
16. Crystallographic insights into a cobalt (III) sepulchrate based alternative cofactor system of P450 BM3 monooxygenase.
Panneerselvam S; Shehzad A; Mueller-Dieckmann J; Wilmanns M; Bocola M; Davari MD; Schwaneberg U
Biochim Biophys Acta Proteins Proteom; 2018 Jan; 1866(1):134-140. PubMed ID: 28739446
[TBL] [Abstract][Full Text] [Related]
17. Are branched chain fatty acids the natural substrates for P450(BM3)?
Cryle MJ; Espinoza RD; Smith SJ; Matovic NJ; De Voss JJ
Chem Commun (Camb); 2006 Jun; (22):2353-5. PubMed ID: 16733577
[TBL] [Abstract][Full Text] [Related]
18. Deazaflavins as mediators in light-driven cytochrome P450 catalyzed hydroxylations.
Zilly FE; Taglieber A; Schulz F; Hollmann F; Reetz MT
Chem Commun (Camb); 2009 Dec; (46):7152-4. PubMed ID: 19921013
[TBL] [Abstract][Full Text] [Related]
19. Redox control of the catalytic cycle of flavocytochrome P-450 BM3.
Daff SN; Chapman SK; Turner KL; Holt RA; Govindaraj S; Poulos TL; Munro AW
Biochemistry; 1997 Nov; 36(45):13816-23. PubMed ID: 9374858
[TBL] [Abstract][Full Text] [Related]
20. Engineering bacterial cytochrome P450 (P450) BM3 into a prototype with human P450 enzyme activity using indigo formation.
Park SH; Kim DH; Kim D; Kim DH; Jung HC; Pan JG; Ahn T; Kim D; Yun CH
Drug Metab Dispos; 2010 May; 38(5):732-9. PubMed ID: 20100815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
